Sundaram Clayton Limited (SUNCLAY) reports a 20.4% EBITDA of Rs. 91.9 Cr for Q4 FY 2025-26, up from 17.0% in Q4 FY 2024-25.
Interarch Building Solutions Limited (INTERARCH) reports Q4 FY26 revenue up 8.7% to INR 504 Cr, PAT down 5.4%.
L&T partners with France-based Exail for Indian Navy’s advanced Unmanned Mine Counter Measure Suite, enhancing maritime security.
Balaji Amines Limited (BALAMINES) announced Q4FY26 results with revenue ₹403 Cr, EBITDA ₹102 Cr, and net profit ₹65 Cr.
Indoco Remedies Limited (INDOCO) receives Malta Medicines Authority audit approval for its Baddi facility, confirming compliance with EU GMP standards.
Alembic Pharmaceuticals Limited (APLLTD) announced USFDA tentative approval for Darolutamide Tablets, 300 mg, with an estimated market size of US$ 3,155 million.
Embassy Developments Limited (EMBDL) secures a favourable Karnataka High Court order; KIADB resumption set aside, ensuring lawful possession of 78 acres.
RattanIndia Enterprises Limited (RTNINDIA) announces Revolt Motors crossing 72 crore electric kilometres, aligning with PM Modi’s vision for sustainable mobility.
Signatureglobal (India) Limited (NSE: SIGNATURE) reports FY26 net profit surge to INR 10.9 billion, revenue up to INR 26.0 billion.
DCM Shriram Limited Q4 FY 2026 results show revenue up 7%, PAT rises 11%, and final dividend at 560%.